Sur, Surojit <br/><br/>
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Mar 2009 
 - 3964-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.0813333106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>G1 Phase--drug effects<br/>Gene Expression Profiling<br/>Gene Targeting<br/>Genotype<br/>Humans<br/>Imidazoles--metabolism<br/>Mice<br/>Neoplasms--pathology<br/>Piperazines--metabolism<br/>Pteridines--pharmacology<br/>Transcription, Genetic--drug effects<br/>Tumor Suppressor Protein p53--genetics<br/>Xenograft Model Antitumor Assays